Daliom Biopharmaceuticals focuses on developing innovative solutions to improve health outcomes
The company's planned product range includes:
Therapeutic proteins
Daliom Biopharmaceuticals invests into the development of therapeutic proteins, such as monoclonal antibodies and recombinant proteins, to treat a range of diseases. This includes immunotherapy for cancer, as well as treatments for autoimmune disorders, rare diseases, and infectious diseases.
Dietary supplements and probiotics
Daliom Biopharmaceuticals is committed to focus' on a comprehensive range of biopharmaceutical products, dietary supplements, and probiotics that are designed to support overall health and wellbeing, by addressing specific health concerns and improving patient outcomes.
